投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
7.8 %
年文章数
460
作者需知
暂无数据
NCBI查询
偏重的研究方向
暂无数据
期刊简介
稿件收录要求
稿件收录要求
Mankind has been at the mercy of viral diseases for millennia. In the current virologic landscape, research is expanding at an unprecedented rate. The fields of virology and genomic research have been closely linked for many years; the first whole genome to be sequenced was viral in origin bacteriophage phi X174, in 1977. Since then, many more viral genomes have been mapped, and with the human genome also available, it is now possible to determine viralhost interactions during infection. This has consequently provided a complete catalogue of potential antiviral targets to be researched. The advent of the HIV pandemic led to a dramatic increase in research in the field of rational drug design, resulting in the large number of antiviral drugs and vaccines entering clinical trials today. The development of drug-resistant mutants and the emergence of new viruses (such as SARS coronavirus and avian influenza H5N1 a virus with pandemic potential) are adding additional burdens to the already time-constrained virology community. The need to move swiftly in the event of a new disease outbreak makes it essential for the virologist to keep up-to-date with all key advances. Future Virology (ISSN: 1746-0794) provides an interdisciplinary forum for all scientists working in the field today.
